Why is Inovio Pharmaceuticals stock skyrocketing 225% today?

More in Finance

• TSMC's massive $6.5 trillion valuation opportunity: Is the Taiwan chipmaker stock to buy for the next 4 years? Decoded

  Sustained worldwide demand for cutting-edge artificial intelligence hardware has positioned the world's leading contract chipmaker for exponential long-term financial expansion. Analysts project the foundry's market worth could surge nearly threefold if it sustains aggressive revenue targets and historical profitability through the end of the decade. This trajectory highlights how critical foundational semiconductor manufacturing remains to the ongoing expansion of enterprise AI technology.

  4 min read
• AppLovin stock faces Unity competition concerns ahead of earnings

  Market participants are closely monitoring competitive pressure between the two tech firms to gauge the potential impact on quarterly results. This rivalry serves as a critical backdrop as investors evaluate financial expectations prior to the scheduled corporate disclosure.

  1 min read
• The latest market wobble sees Citi giving up on this big tech trade

  Financial strategists at the major bank have decided to unwind a prominent position tied to the technology sector as recent market volatility shifts risk dynamics. The strategic retreat marks a significant change in stance following broad fluctuations that impacted high-profile tech assets. Investors and institutional clients may see this repositioning as a broader signal to re-evaluate their exposure to similar mega-cap trades.

  1 min read